• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $HLF

    Herbalife Ltd.

    Subscribe to $HLF
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which include functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products comprising N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that include start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

    IPO Year: 2004

    Exchange: NYSE

    Website: herbalife.com

    Recent Analyst Ratings for Herbalife Ltd.

    DatePrice TargetRatingAnalyst
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    5/17/2022Buy → Hold
    Argus
    5/4/2022$60.00 → $26.00Buy → Hold
    Jefferies
    11/18/2021$15.00 → $16.00Sector Perform
    RBC Capital
    9/16/2021$57.00 → $52.00Buy
    Citigroup
    See more ratings

    Herbalife Ltd. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      11/14/24 4:11:11 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G filed by Herbalife Ltd.

      SC 13G - HERBALIFE LTD. (0001180262) (Subject)

      11/13/24 4:01:31 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      11/13/24 12:49:27 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      11/7/24 1:14:51 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      2/14/24 5:53:54 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      2/14/24 4:00:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      2/13/24 5:06:16 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      2/13/24 10:52:19 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      2/8/24 2:58:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G filed by Herbalife Nutrition Ltd.

      SC 13G - HERBALIFE NUTRITION LTD. (0001180262) (Subject)

      2/14/23 5:05:26 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    Herbalife Ltd. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      6/9/25 6:00:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/23/25 4:01:25 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,650 worth of shares (5,000 units at $6.73) and was granted 21,857 shares, increasing direct ownership by 20% to 161,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:19:33 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $20,000 worth of shares (2,500 units at $8.00), increasing direct ownership by 2% to 135,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      3/6/25 5:11:51 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $41,250 worth of shares (5,000 units at $8.25), increasing direct ownership by 4% to 132,500 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      3/3/25 5:45:46 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $21,225 worth of shares (2,500 units at $8.49), increasing direct ownership by 2% to 127,500 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      11/13/24 4:44:45 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $39,950 worth of shares (5,000 units at $7.99), increasing direct ownership by 4% to 125,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      11/5/24 6:33:07 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $71,100 worth of shares (10,000 units at $7.11), increasing direct ownership by 9% to 120,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      9/9/24 6:14:06 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $87,200 worth of shares (10,000 units at $8.72), increasing direct ownership by 10% to 110,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      8/27/24 5:40:07 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $53,835 worth of shares (6,721 units at $8.01), increasing direct ownership by 7% to 100,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      8/14/24 4:30:41 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    Herbalife Ltd. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Herbalife's Aloin Identification Method for Aloe Vera Officially Recognized by AOAC INTERNATIONAL

      Certified Method Enhances Global Botanical Quality and Safety Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the Association of Official Analytical Collaboration (AOAC INTERNATIONAL)—a global authority in analytical science—has formally certified its proprietary method for identifying and measuring anthraquinones, also known as aloins, in aloe vera. Aloe regulatory groups require producers of ingestible aloe vera products to monitor naturally occurring compounds such as aloin A, aloin B, and aloe-emodin to meet safety guidelines. This certification officially recognizes Herbalife's longstanding method as the world's first AOAC-app

      6/11/25 7:14:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Participate in MicroCap Rodeo Conference on June 4

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will participate in a fireside chat at the MicroCap Rodeo Conference on Wednesday, June 4, 2025 at 9:30 a.m. ET (6:30 a.m. PT). The webcast will be available at the following link: https://www.webcaster4.com/Webcast/Page/3119/52530 The webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event and for six months thereafter. For more details about the MicroCap Rodeo Conference in New

      5/27/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Q1 Net Sales at Midpoint of Guidance Range, Net Sales Growth Excluding FX Headwinds1; Q1 Adjusted EBITDA2 Exceeds Guidance; Updates Full-Year Guidance

      Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430667438/en/ "Our first quarter results were strong, and we raised our full-year 2025 Adjusted EBITDA2 expectations. Our recent acquisitions strengthen our position and support our commitment to transformative growth," Stephan Gratziani, President and incoming CEO (effective May 1 '25). Highlights First Quarter 2025 Net sales of $1.2 billion at midpoint of guidance range Down 3.4% vs. Q1 ‘24 Includes 480 basis points of FX headwinds Up 1.4% year-over-year on constant cu

      4/30/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Welcomes Lynda Cloud to its Board of Directors

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

      4/25/25 5:12:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Renews Its Support for the LA Galaxy Special Olympics Unified Team for the 2025 Season

      Herbalife Serves as Official Nutrition Partner, Offering Athletes the Same Elite Support it Provides to Pro Players Herbalife, a premier health and wellness company, community and platform, today announced that it has renewed its support of the LA Galaxy Special Olympics Unified Team for the 2025 season. This partnership will offer Special Olympics athletes—ages 16 to 25—access to the same high-quality resources as the professional team including world-class nutrition education, elite training, and exclusive experiences, such as access to professional team gear, travel, scrimmages, and matches against other MLS Unified Teams. This press release features multimedia. View the full release he

      4/3/25 11:21:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce First Quarter 2025 Results on April 30

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2025 financial results after the close of trading on the NYSE on Wednesday, April 30, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/bd8j8th6 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI1210

      4/1/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Fuels the Women's College All-Star Game as Official Nutrition and Hydration Sponsor

      Global Health and Wellness Leader Supports Female Athletes with Personalized Nutrition LOS ANGELES, March 24, 2025 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, today announced it will fuel the Women's College All-Star Game as its Official Nutrition and Hydration Sponsor. Set to take place during the national championship weekend on April 5 in Tampa, Fla., the Women's College All-Star Game will showcase 20 of the nation's top collegiate basketball players as they compete one final time before entering the next phase of their careers – including opportunities in the WNBA*. Through this sponsorship, Herbalife is furthering its commitment to addressi

      3/24/25 7:00:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Acquire Assets of Pro2col Health and Pruvit Ventures, and Controlling Ownership Interest in Link BioSciences

      Accelerates Journey to Become the World's Premier Health and Wellness Platform Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced it has entered into a binding memorandum of understanding to acquire 100% of the assets of Pro2col Health LLC (Pro2col) and Pruvit Ventures, Inc. (Pruvit), as well as a 51% controlling ownership interest in Link BioSciences Inc. (Link BioSciences). Pro2col is a health and wellness digital application company, which will use individual biometrics to provide personalized nutrition recommendations in support of a healthy, active lifestyle. The platform is designed to deliver tailored health and longevity proto

      3/12/25 1:00:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Q4 Net Sales at High End of Guidance, Q4 and Full-Year Net Sales Growth Excluding FX Headwinds1; Q4 Adjusted EBITDA2 Exceeds Guidance

      Stephan Gratziani Appointed CEO; Michael Johnson Named Executive Chairman Herbalife Ltd. (NYSE:HLF) today reported financial results for the fourth quarter and year ended December 31, 2024: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219267078/en/ "With three consecutive quarters of new distributor growth, a new incoming CEO and significantly improved Adjusted EBITDA2 margins, we enter 2025 with strong momentum." - Michael Johnson, Chairman and CEO Highlights Fourth Quarter 2024 Net sales of $1.2 billion, down 0.6% vs. Q4 '23 and at high end of guidance range Includes 330 basis points of FX headwinds Up 2.7% year-o

      2/19/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints Stephan Gratziani as Chief Executive Officer

      Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

      2/19/25 4:05:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    Herbalife Ltd. SEC Filings

    See more
    • Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - HERBALIFE LTD. (0001180262) (Filer)

      4/30/25 4:40:01 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by Herbalife Ltd.

      10-Q - HERBALIFE LTD. (0001180262) (Filer)

      4/30/25 4:16:43 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.

      SCHEDULE 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      4/30/25 11:12:30 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form 8-K filed by Herbalife Ltd.

      8-K - HERBALIFE LTD. (0001180262) (Filer)

      4/25/25 5:15:06 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form DEFA14A filed by Herbalife Ltd.

      DEFA14A - HERBALIFE LTD. (0001180262) (Filer)

      3/11/25 5:25:21 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form DEF 14A filed by Herbalife Ltd.

      DEF 14A - HERBALIFE LTD. (0001180262) (Filer)

      3/11/25 5:23:53 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - HERBALIFE LTD. (0001180262) (Filer)

      2/19/25 4:30:16 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-K filed by Herbalife Ltd.

      10-K - HERBALIFE LTD. (0001180262) (Filer)

      2/19/25 4:22:06 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.

      SCHEDULE 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      2/13/25 4:17:06 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.

      SCHEDULE 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      2/13/25 9:54:56 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    Herbalife Ltd. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Herbalife Nutrition upgraded by DA Davidson with a new price target

      DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

      3/21/25 8:38:07 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • B. Riley Securities reiterated coverage on Herbalife Nutrition with a new price target

      B. Riley Securities reiterated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $17.00 from $16.00 previously

      8/1/24 8:12:23 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • DA Davidson initiated coverage on Herbalife Nutrition with a new price target

      DA Davidson initiated coverage of Herbalife Nutrition with a rating of Neutral and set a new price target of $13.50

      9/14/23 7:19:53 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Mizuho initiated coverage on Herbalife Nutrition with a new price target

      Mizuho initiated coverage of Herbalife Nutrition with a rating of Neutral and set a new price target of $13.00

      6/7/23 7:55:26 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • BofA Securities initiated coverage on Herbalife Nutrition with a new price target

      BofA Securities initiated coverage of Herbalife Nutrition with a rating of Underperform and set a new price target of $14.00

      2/3/23 7:23:34 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Nutrition upgraded by Jefferies with a new price target

      Jefferies upgraded Herbalife Nutrition from Hold to Buy and set a new price target of $26.00

      7/12/22 9:15:11 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Nutrition downgraded by Argus

      Argus downgraded Herbalife Nutrition from Buy to Hold

      5/17/22 9:07:57 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Nutrition downgraded by Jefferies with a new price target

      Jefferies downgraded Herbalife Nutrition from Buy to Hold and set a new price target of $26.00 from $60.00 previously

      5/4/22 6:12:06 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • RBC Capital reiterated coverage on High Liner Foods with a new price target

      RBC Capital reiterated coverage of High Liner Foods with a rating of Sector Perform and set a new price target of $16.00 from $15.00 previously

      11/18/21 6:57:35 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Citigroup reiterated coverage on Herbalife Nutrition with a new price target

      Citigroup reiterated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $52.00 from $57.00 previously

      9/16/21 7:49:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    Herbalife Ltd. Leadership Updates

    Live Leadership Updates

    See more
    • Herbalife Welcomes Lynda Cloud to its Board of Directors

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

      4/25/25 5:12:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints Stephan Gratziani as Chief Executive Officer

      Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

      2/19/25 4:05:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Expands Board of Directors with Appointment of Perkins Miller

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller's appointment as an independent director is effective June 26, 2024. "Perkins brings valuable, proven expertise in leading large-scale e-commerce, technology and sports enterprises, which will be a great asset to our Board as the Company continues to grow and transform," said Michael Johnson, Chairman and CEO of Herbalife. Miller is the CEO of Fandom, the world's largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has trans

      6/26/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Announces CFO Transition; Initiates Guidance for First Quarter and Full-Year 2024

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the appointment of John DeSimone as Chief Financial Officer, succeeding Alex Amezquita who will remain with the Company. Mr. DeSimone has been an executive at Herbalife for the past 17 years, including more than 8 years as CFO from 2010 – 2018 and 4 years as President and Co-President from 2018 – 2022. Most recently, he served as a Special Advisor to the CEO. "John is a talented and proven finance leader, who has immense experience with Herbalife and a successful track record," said Michael Johnson, Chairman and Chief Executive Officer. "We believe with Stephan Gratziani as President

      3/20/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Welcomes Back Michael Levitt to Board of Directors

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, today announced the appointment of veteran finance executive, Michael Levitt, to its Board of Directors, effective March 1, 2024. Levitt previously served on the Company's Board as the Lead Director from 2011 to 2014. Kevin Jones, who has served as a director since 2021, will step down from his role on the Board. "We are honored to welcome Michael back to our Board," said Michael Johnson, Chairman and CEO of Herbalife. "Michael's deep financial expertise, understanding of our business and shared passion for Herbalife's vision will further strengthen our Board." Levitt is the Chairman of Irradiant Partners, LP, an investme

      3/7/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints Chief Strategy Officer, Stephan Gratziani, to President

      Herbalife, a premier health and wellness company, today announced the appointment of Stephan Paulo Gratziani to President, effective January 2, 2024, as part of the Company's management succession planning process. Mr. Gratziani will continue to report directly to Chairman and Chief Executive Officer, Michael Johnson. "Stephan hit the ground running and has demonstrated his extensive knowledge of the business and strategic strength in his role as Chief Strategy Officer," said Michael Johnson, Chairman and CEO. "Stephan has an innate ability to lead, drive change and inspire others. We believe his innovative mindset and vast experience as a former leading independent distributor position h

      1/2/24 4:30:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints Former Amway Chief People Officer, Claire V. Groen, to Chief Human Resource Officer

      Herbalife, a premier health and wellness company, announced today that Claire V. Groen has been named the new Chief Human Resource Officer, effective immediately, and is reporting to executive vice president and Chief of Staff, Ibi Montesino. Ms. Groen is the former Chief People Officer at Amway. In this role Ms. Groen is responsible for Herbalife's global human resource strategy and function in support of Herbalife's overall business plan. This includes providing leadership in the areas of employee engagement and culture, talent acquisition and organization design and development, diversity and inclusion, employee relations, leadership development, employee education and training, compen

      10/19/23 9:48:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints Independent Distributor Ms. Rodica Macadrai to Board of Directors

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company today announced, as part of its governance process, the Herbalife Board of Directors has appointed independent distributor, Ms. Rodica Macadrai, as a new member to the Board, effective September 10, 2023. "Rodica will be a valuable addition to our Board, and we look forward to her insight and contributions as an experienced independent distributor in helping guide Board decisions," said Michael Johnson, Chairman and CEO. Ms. Macadrai became an Herbalife independent distributor in 1994 in Moldova, immediately after having earned a Doctor of Medicine in Psychology from Babes Bolyai University in Cluj Napoca, Romania. Over th

      9/14/23 4:40:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints A Top Distributor, Stephan Gratziani, Chief Strategy Officer

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company and community, today announced the appointment of Stephan Paulo Gratziani to Chief Strategy Officer, effective August 4, 2023. Mr. Gratziani will report directly to Chairman and Chief Executive Officer Michael Johnson and work closely with the Company's senior management team to implement and advance key strategic initiatives, including the Herbalife One digital technology platform and business verticals. He will also partner with senior executive and regional leadership to enhance sales training programs, promote distributor engagement, and identify growth opportunities. Mr. Gratziani brings over 32 years of experience to H

      8/2/23 4:09:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Announces Leadership Succession Plan

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company and community, today announced senior executive leadership changes. As part of its succession management process, the Company is announcing Mark Schissel's retirement after 16 years of leadership contributions on July 1. Frank Lamberti will be appointed to Chief Operating Officer. In addition, the Company is announcing the expanded role of Ibi Montesino, EVP and Chief of Staff, and the appointment of Rob Levy to Regional President of the Americas. All three executives will assume their roles effective July 1, 2023 and report directly to Michael Johnson, Chief Executive Officer. Schissel will assume a strategic advisory role to

      5/2/23 4:13:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    Herbalife Ltd. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      6/9/25 6:00:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/23/25 4:01:25 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • New insider Levy Robert claimed ownership of 449,358 shares (SEC Form 3)

      3 - HERBALIFE LTD. (0001180262) (Issuer)

      5/12/25 7:39:33 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • New insider Montesino Ibelis claimed ownership of 33,499 shares (SEC Form 3)

      3 - HERBALIFE LTD. (0001180262) (Issuer)

      5/12/25 7:37:49 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Chief Legal Officer Wang Henry C covered exercise/tax liability with 10,540 shares, decreasing direct ownership by 7% to 148,977 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 9:23:21 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Gratziani Stephan Paulo covered exercise/tax liability with 7,873 shares, decreasing direct ownership by 6% to 122,310 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:56:03 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SVP, PAO Irani Jehangir D covered exercise/tax liability with 9,035 shares, decreasing direct ownership by 14% to 55,424 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:51:51 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Chief Operating Officer Hicks Troy covered exercise/tax liability with 6,201 shares, decreasing direct ownership by 11% to 50,246 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:47:44 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Cloud Lynda was granted 21,857 shares (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:44:37 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Miller Perkins was granted 25,273 shares, increasing direct ownership by 213% to 37,143 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:40:21 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    Herbalife Ltd. Financials

    Live finance-specific insights

    See more
    • Herbalife Reports Q1 Net Sales at Midpoint of Guidance Range, Net Sales Growth Excluding FX Headwinds1; Q1 Adjusted EBITDA2 Exceeds Guidance; Updates Full-Year Guidance

      Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430667438/en/ "Our first quarter results were strong, and we raised our full-year 2025 Adjusted EBITDA2 expectations. Our recent acquisitions strengthen our position and support our commitment to transformative growth," Stephan Gratziani, President and incoming CEO (effective May 1 '25). Highlights First Quarter 2025 Net sales of $1.2 billion at midpoint of guidance range Down 3.4% vs. Q1 ‘24 Includes 480 basis points of FX headwinds Up 1.4% year-over-year on constant cu

      4/30/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce First Quarter 2025 Results on April 30

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2025 financial results after the close of trading on the NYSE on Wednesday, April 30, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/bd8j8th6 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI1210

      4/1/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Q4 Net Sales at High End of Guidance, Q4 and Full-Year Net Sales Growth Excluding FX Headwinds1; Q4 Adjusted EBITDA2 Exceeds Guidance

      Stephan Gratziani Appointed CEO; Michael Johnson Named Executive Chairman Herbalife Ltd. (NYSE:HLF) today reported financial results for the fourth quarter and year ended December 31, 2024: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219267078/en/ "With three consecutive quarters of new distributor growth, a new incoming CEO and significantly improved Adjusted EBITDA2 margins, we enter 2025 with strong momentum." - Michael Johnson, Chairman and CEO Highlights Fourth Quarter 2024 Net sales of $1.2 billion, down 0.6% vs. Q4 '23 and at high end of guidance range Includes 330 basis points of FX headwinds Up 2.7% year-o

      2/19/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce Fourth Quarter and Full-Year 2024 Results on February 19

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its fourth quarter and full-year 2024 financial results after the close of trading on the NYSE on Wednesday, February 19, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host a live audio webcast and conference call to discuss its recent financial results. The live audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/mssckczw Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register.vevent.c

      1/3/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Third Quarter 2024 Results, Net Sales In Line with Expectations, Adjusted EBITDA1 Exceeds Guidance; Raised Full-Year Adjusted EBITDA1 Guidance

        Herbalife Ltd. (NYSE:HLF) today reported financial results for the third quarter ended September 30, 2024: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030736401/en/ "Our financial foundation is strong. Third quarter net sales were in line with our expectations, adjusted EBITDA1 exceeded guidance and distributor recruiting is up worldwide year-over-year. Our new business initiatives are taking root as we continue on our path to sustainable top-line growth." - Michael Johnson, Chairman and CEO Highlights Third Quarter 2024 Net sales of $1.2 billion, down 3.2% vs. Q3 '23 including 290 basis points of FX headwinds Net

      10/30/24 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce Third Quarter 2024 Results on October 30

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its third quarter 2024 financial results after the close of trading on the NYSE on Wednesday, October 30, 2024. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host a live audio webcast and conference call to discuss its recent financial results. The live audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/i5tx7naj Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register.vevent.com/register/BIe462

      10/1/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Second Quarter 2024 Results, Adjusted EBITDA1 Exceeds Guidance; Raised Full-Year Adjusted EBITDA1 Guidance

      Herbalife Ltd. (NYSE:HLF) today reported financial results for the second quarter ended June 30, 2024: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240730118998/en/ "Our Q2 Adjusted EBITDA1 is the highest it's been in seven quarters. We remain focused on driving shareholder value as the continued increase in new distributors builds the foundation for sales growth." - Michael Johnson, Chairman and CEO Highlights Second Quarter 2024 Net sales of $1.3 billion, down 2.5% vs. Q2 '23 due to 270 basis points of FX headwinds Achieved year-over-year net sales growth on constant currency basis2, up 0.2%, driven by increases in La

      7/31/24 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce Second Quarter 2024 Results on July 31

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its second quarter 2024 financial results after the close of trading on the NYSE on Wednesday, July 31, 2024. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host a live audio webcast and conference call to discuss its recent financial results. The live audio webcast will be available at the following link: Financial Results Webcast. Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: Conference Call Registration. The earnings release, supplem

      7/1/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Year-Over-Year Net Sales Growth for Second Consecutive Quarter; Raises Full-Year 2024 Adjusted EBITDA1 Guidance

      Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240430842240/en/ "We achieved our second consecutive quarter of year-over-year net sales growth. We are laser focused on cost reductions, which drove outperformance of our Adjusted EBITDA1 guidance," said Michael Johnson, Chairman and CEO. Highlights First Quarter 2024 Achieved year-over-year net sales growth on both reported and constant currency basis2 Net sales of $1.3 billion, up 1.0% vs. 1Q '23, in-line with guidance; on constant currency basis2 up 2.4% Net inco

      5/1/24 4:35:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce First Quarter 2024 Results on May 1

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2024 financial results after the close of trading on the NYSE on Wednesday, May 1, 2024. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host a live audio webcast and conference call to discuss its recent financial results and provide an update on current business trends. The live audio webcast will be available at https://edge.media-server.com/mmc/p/8s4dwfp6. Participants joining via the conference call, may obtain the dial-in information and personal PIN to access the call by registering at https://register.vevent.com/registe

      4/2/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care